Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
August 18, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
Retired NFL Players, Wives Form Player Advocacy Committee to Help Retired Players in the NFL Concussion Settlement; Class Counsel to Support Efforts
August 16, 2022 10:00 ET
|
Player Advocacy Committee for the NFL Concussion Settlement
WASHINGTON, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Dr. Amy Lewis, chair of the newly-created Player Advocacy Committee and wife of retired NFL player Kenneth Jenkins, announced a collaboration with Chris...
Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion
August 10, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-improving medical products,...
IBN (InvestorBrandNetwork) Announces ‘Get Authentic’ Interview with NFL Hall of Famer Brett Favre and Odyssey Health Inc.’s Dr. Jacob VanLandingham
August 09, 2022 08:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN, a multifaceted financial news and publishing company for private and public entities, today announces that NFL Hall of Famer...
electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference
August 05, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan...
electroCore Announces Record Second Quarter 2022 Financial Results
August 04, 2022 16:05 ET
|
electroCore, Inc.
Record second quarter 2022 net sales of $2.2 million, increased 70% over second quarter 2021 and 14% sequentially Company to host a conference call and webcast today, August 4, 2022 at 4:30 pm EDT ...
Odyssey Health, Inc. Launches New Corporate Website
August 04, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products, is...
electroCore to Announce Second Quarter 2022 Financial Results on August 4
July 28, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the...
Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug
July 12, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, July 12, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
electroCore, Inc. Announces Study of gammaCore Sapphire™ for the Treatment of Post-COVID Syndrome
July 07, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., July 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced Mayo Clinic is initiating an...